First-Line Immune Checkpoint Therapy in Metastatic Squamous Cell Lung Cancer Harboring Both EGFR Mutation and High Expression of PD-L1: A Case Report

Thoracic Cancer - Australia

doi 10.1111/1759-7714.13436